DS
JANX icon

DRW Securities’s Janux Therapeutics JANX Stock Holding History

DRW Securities’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$303K Buy
+19,749
New +$286K 0.01% 613
2025
Q4 		– Sell
-21,543
Closed -$517K – 1461
2025
Q3 		$517K Buy
21,543
+8,977
+71% +$219K 0.01% 594
2025
Q2 		$290K Buy
+12,566
New +$331K 0.01% 753

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

DRW Securities's JANX Position: Q2 2026 in Review

DRW Securities opened a new position in Janux Therapeutics (JANX) in Q2 2026: 19,749 shares worth $303K. The stake represents 0.01% of the portfolio and ranks #613 among its holdings. This is a return to the name: DRW Securities previously reported a position in JANX as recently as Q3 2025.

DRW Securities first reported a position in JANX in Q2 2025 and has held it in 3 quarters since. The position peaked at $517K in Q3 2025. 197 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • DRW Securities held 19,749 shares of Janux Therapeutics worth $303K as of Q2 2026.
  • Janux Therapeutics was a new DRW Securities position in Q2 2026.
  • Janux Therapeutics made up 0.01% of DRW Securities's portfolio in Q2 2026, its #613 holding.
  • DRW Securities first reported a position in Janux Therapeutics in Q2 2025 and has held it in 3 quarters since.
  • DRW Securities's Janux Therapeutics position peaked at $517K in Q3 2025.
  • 197 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.